The Clorox Company (NYSE:CLX) Shares Sold by Private Advisor Group LLC

Private Advisor Group LLC reduced its position in shares of The Clorox Company (NYSE:CLX) by 1.7% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 32,444 shares of the company’s stock after selling 547 shares during the period. Private Advisor Group LLC’s holdings in Clorox were worth $4,428,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. SG Americas Securities LLC lifted its position in shares of Clorox by 1,525.7% in the 1st quarter. SG Americas Securities LLC now owns 65,612 shares of the company’s stock worth $10,046,000 after buying an additional 61,576 shares during the last quarter. Mizuho Markets Americas LLC lifted its holdings in Clorox by 93.7% in the first quarter. Mizuho Markets Americas LLC now owns 72,053 shares of the company’s stock worth $11,032,000 after acquiring an additional 34,864 shares during the last quarter. CANADA LIFE ASSURANCE Co boosted its stake in Clorox by 15.2% in the first quarter. CANADA LIFE ASSURANCE Co now owns 141,622 shares of the company’s stock valued at $21,705,000 after acquiring an additional 18,687 shares during the period. Advisors Asset Management Inc. grew its holdings in shares of Clorox by 257.5% during the first quarter. Advisors Asset Management Inc. now owns 11,228 shares of the company’s stock valued at $1,719,000 after purchasing an additional 8,087 shares during the last quarter. Finally, Game Plan Financial Advisors LLC acquired a new stake in shares of Clorox during the 1st quarter worth approximately $1,025,000. 78.53% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on the company. Wells Fargo & Company lowered their price objective on Clorox from $135.00 to $130.00 and set an “underweight” rating for the company in a research note on Wednesday, July 10th. BNP Paribas upgraded shares of Clorox to a “strong sell” rating in a research report on Friday, September 6th. JPMorgan Chase & Co. decreased their target price on shares of Clorox from $150.00 to $148.00 and set a “neutral” rating for the company in a research report on Friday, August 2nd. Deutsche Bank Aktiengesellschaft lifted their price target on Clorox from $144.00 to $151.00 and gave the company a “hold” rating in a report on Friday, August 2nd. Finally, DA Davidson restated a “neutral” rating and issued a $153.00 target price on shares of Clorox in a research report on Friday, September 6th. Six research analysts have rated the stock with a sell rating and thirteen have assigned a hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $143.50.

Insider Buying and Selling

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the company’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the sale, the executive vice president now directly owns 13,471 shares of the company’s stock, valued at $2,229,719.92. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 0.51% of the stock is currently owned by company insiders.

Clorox Price Performance

Shares of NYSE CLX opened at $166.96 on Wednesday. The firm has a 50-day moving average of $144.22 and a two-hundred day moving average of $142.97. The company has a market capitalization of $20.68 billion, a price-to-earnings ratio of 86.51, a PEG ratio of 3.34 and a beta of 0.40. The company has a current ratio of 1.03, a quick ratio of 0.63 and a debt-to-equity ratio of 5.04. The Clorox Company has a twelve month low of $114.68 and a twelve month high of $167.75.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Thursday, August 1st. The company reported $1.82 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.54 by $0.28. Clorox had a net margin of 3.95% and a return on equity of 281.12%. The firm had revenue of $1.90 billion for the quarter, compared to analyst estimates of $1.97 billion. As a group, analysts expect that The Clorox Company will post 6.56 earnings per share for the current fiscal year.

Clorox Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, August 30th. Stockholders of record on Wednesday, August 14th were issued a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a dividend yield of 2.92%. This is an increase from Clorox’s previous quarterly dividend of $1.20. The ex-dividend date of this dividend was Tuesday, August 13th. Clorox’s dividend payout ratio is currently 252.85%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.